# Sources — Mumtaz Mahal

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Department of Tourism, Government of Uttar Pradesh. Taj Mahal official website: “Mumtaz Mahal” and “About Empress Mumtaz Mahal.” Supports her full name Arjumand Banu Begum, birth in Agra in April 1593, death on 17 June 1631 at Burhanpur, and burial in the Taj Mahal; her father “Abdul Hasan Asaf Khan, a Persian noble” and her aunt the Empress Nur Jahan; that she was “a Shi'a Muslim”; her betrothal in 1607 and marriage on 10 May 1612; the title “'Mumtaz Mahal' Begum (Chosen One of the Palace)”; that “despite her frequent pregnancies, Mumtaz traveled with Shah Jahan's entourage throughout his earlier military campaigns”; that she died at Burhanpur in the Deccan “during the birth of their thirtheenth [sic] child, a daughter named Gauhara Begum”; her temporary burial in the Zainabad garden on the Tapti River and the removal of her body to Agra in December 1631. It lists thirteen children with their years. https://tajmahal.gov.in/the-cause-of-the-taj.aspx and https://tajmahal.gov.in/about-mumtaz-mahal.aspx
2. Elliot HM, Dowson J, editors. *The History of India as Told by Its Own Historians: The Muhammadan Period*, Volume VII. London: Trübner; 1877. Internet Archive. The extract from the *Badshah-nama* of Abdul Hamid Lahori, fourth year of the reign (1040 AH, 1630): the emperor's soup kitchens during the Deccan and Gujarat famine and the alms given “so long as His Majesty remained at Burhanpur”; and the death of the Queen: “On the 17th Zi-l ka'da, 1040, died Nawab 'Aliya Begam, in the fortieth year of her age, to the great grief of her husband the Emperor … She had borne him eight sons and six daughters,” with the editors' note “Otherwise called ‘Mumtaz Mahal.’ She died in childbirth.” https://archive.org/details/india.history.resource.309
3. Wikipedia. “Mumtaz Mahal.” Supports her birth as Arjumand Banu on 27 April 1593 in Agra (citing Kamboh's *Shah Jahan-Nama*); her mother's family from Qazvin; the title, rendered “the Exalted One of the Palace”; the table of fourteen children with their dates (including Husn Ara, born 23 April 1630, and a son who died soon after birth in 1622, and the deaths of Hur-ul-Nisa and Surayya Banu of smallpox); that she “died from postpartum hemorrhage in Burhanpur on 17 June 1631 while giving birth to her 14th child, after a prolonged labor of around 30 hours,” citing Kumar (2014) and Kamboh; that she was accompanying her husband on campaign in the Deccan; and her burial. https://en.wikipedia.org/wiki/Mumtaz_Mahal
4. Longstaff A. *Calendars from around the world.* Royal Museums Greenwich. The Islamic calendar is lunar, with years of about 354 days, so a Hijri age runs ahead of a solar age. https://www.rmg.co.uk/sites/default/files/Calendars-from-around-the-world.pdf
5. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine. *Pregnancy at Age 35 Years or Older* (Obstetric Care Consensus No. 11). *Obstet Gynecol* 2022;140(2):348–366, with a 2023 correction. PMID 35852294. The abstract was read: pregnancy at 35 or older carries increased risks of adverse outcomes for the patient and fetus even without other conditions. The specific surveillance and delivery-timing recommendations were not read in full; the record offers, rather than requires, weekly fetal monitoring from 36 weeks and induction at 39 weeks. https://pubmed.ncbi.nlm.nih.gov/35852294/
2. American College of Obstetricians and Gynecologists. *Practice Bulletin No. 183: Postpartum Hemorrhage.* *Obstet Gynecol* 2017;130(4):e168–e186. PMID 28937571. Hemorrhage defined as cumulative blood loss of 1,000 mL or more, or blood loss with signs of hypovolemia, within 24 hours of birth; risk factors, evaluation, prevention, and standardized hemorrhage bundles. https://pubmed.ncbi.nlm.nih.gov/28937571/
3. World Health Organization. *WHO recommendations for the prevention and treatment of postpartum haemorrhage* (2012). Uterotonics for every birth, with oxytocin as the recommended drug, as part of active management of the third stage. The publication page was read; the guideline itself was not. https://www.who.int/publications/i/item/9789241548502
4. World Health Organization. *WHO recommendation on tranexamic acid for the treatment of postpartum haemorrhage* (2017), which supersedes the 2012 recommendation on tranexamic acid: early intravenous tranexamic acid, within 3 hours of birth, in addition to standard care for clinically diagnosed postpartum hemorrhage. The publication page was read. https://www.who.int/publications/i/item/9789241550154
5. WOMAN Trial Collaborators. “Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN).” *Lancet* 2017;389(10084):2105–2116. PMID 28456509. The abstract: 1 g intravenous tranexamic acid, with a second 1 g dose if bleeding continued after 30 minutes or restarted within 24 hours, reduced death due to bleeding (1.5 vs 1.9 percent), especially when given within 3 hours of birth (1.2 vs 1.7 percent), with no adverse effects; it should be given as soon as possible after bleeding begins. https://pubmed.ncbi.nlm.nih.gov/28456509/
6. American College of Obstetricians and Gynecologists. *Anemia in Pregnancy* (Practice Bulletin No. 233). *Obstet Gynecol* 2021;138(2):e55–e64. PMID 34293770. Iron deficiency and blood loss are the commonest causes of anemia in pregnancy; screening and management, including intravenous iron when oral iron fails or is not tolerated. https://pubmed.ncbi.nlm.nih.gov/34293770/
7. American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine. *Placenta Accreta Spectrum* (Obstetric Care Consensus No. 7, 2018). PMID 30461695. https://pubmed.ncbi.nlm.nih.gov/30461695/
8. American College of Obstetricians and Gynecologists. *Gestational Diabetes Mellitus* (Practice Bulletin No. 190, 2018). PMID 29370047. Early screening with risk factors, including a BMI of 23 or more in Asian American women with another risk factor; the one-hour 50 g challenge at 24 to 28 weeks. https://pubmed.ncbi.nlm.nih.gov/29370047/
9. American College of Obstetricians and Gynecologists. *Air Travel During Pregnancy* (Committee Opinion No. 746, 2018). PMID 30045212. https://pubmed.ncbi.nlm.nih.gov/30045212/
10. American College of Obstetricians and Gynecologists and Society for Maternal-Fetal Medicine. *Interpregnancy Care* (Obstetric Care Consensus No. 8, 2019). PMID 30575677. The abstract: interpregnancy care continues from postpartum care and includes reproductive life planning. The advice to avoid an interval under six months and to wait at least 18 months is the consensus document's published guidance; the full text was not read. https://pubmed.ncbi.nlm.nih.gov/30575677/
11. Centers for Disease Control and Prevention. *U.S. Medical Eligibility Criteria for Contraceptive Use, 2024*, for the safety of an implant after birth and with breastfeeding. The page returned HTTP 403 to automated requests and was not read. https://www.cdc.gov/contraception/hcp/usmec/index.html
12. U.S. Preventive Services Task Force: *Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality* (2021) and the A and B recommendations; ACOG *Screening for Fetal Chromosomal Abnormalities* (Practice Bulletin No. 226, 2020, PMID 32804883); ACOG *Screening and Diagnosis of Mental Health Conditions During Pregnancy and Postpartum* (Clinical Practice Guideline No. 4, 2023); and the CDC *Guidelines for Vaccinating Pregnant Persons* (influenza in any trimester; Tdap at 27 to 36 weeks). https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
13. Nicolle LE, et al. “Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America.” *Clin Infect Dis* 2019;68(10):e83–e110. PMID 30895288. Screening and treatment of bacteriuria in pregnancy. https://pubmed.ncbi.nlm.nih.gov/30895288/

The CMID has no monograph for pregnancy, anemia in pregnancy, or postpartum hemorrhage, so ACOG Obstetric Care Consensus No. 11, ACOG Practice Bulletins 183 and 233, and the WHO recommendations are the specialty guidelines for the monitoring protocol.

## Editorial resolutions

- **Name.** “Mumtaz Mahal” is a title, not a given and family name; split at the last space it would give the family name “Mahal”. Following the dataset's practice for single names, `identity.name_parts` is given [], family "Mumtaz Mahal", so the C-CDA and FHIR names are both “Mumtaz Mahal” with no given name, and the notes call her Mumtaz Mahal, the form she is recorded as preferring. Her birth name, “Arjumand Banu Begum”, appears in no other record and is the alias; “Begum” is an honorific, so it is not treated as a family name. The chronicle's “Nawab 'Aliya Begam” is recorded in the claim text only.
- **Dates and calendars.** Mughal court chronicles date events in the Hijri (Islamic lunar) calendar. Lahori gives her death as 17 Zi-l ka'da (Dhu al-Qa'da) 1040 AH; by the tabular Islamic calendar this is 17 June 1631 (Gregorian), the date in the other sources, checked by computing Julian day numbers; a date fixed by sighting the new moon can differ by a day. The state tourism page says she died on a Wednesday; 17 June 1631 was a Tuesday, and the Islamic day begins at sunset, so a death in the evening would fall on the Wednesday; this is noted, not resolved. Lahori's “fortieth year of her age” is a lunar count; by the Gregorian calendar she was 38. No Hijri birth date was found; the preferred birth date is 27 April 1593 (the encyclopedia, citing Kamboh), with the tourism page's “April 1593” agreeing. Dates in 1593 to 1631 given by modern sources are Gregorian.
- **Index age and dates.** The episode presents her at 37 in her fourteenth pregnancy. The synthetic date of birth is April 27, 1988, so the whole-year shift is 395 years and 2026 maps to 1631. She died on June 17, 1631, so every visit had to fall between January 1 and June 16, 2026; that rules out the late-1630 index the assignment suggested (a late-2026 index would leave only weeks before the November 1 cutoff, too short for prenatal care). The index visit is January 6, 2026, at 13 weeks 2 days by ultrasound (true frame January 6, 1631, when the court was at Burhanpur); the follow-ups are February 3 (consultation), March 3, April 14, and June 2, and the sick visit March 24, 2026 (true frame the same days of 1631). She is 37 until April 27 and 38 at the last visit. The ultrasound dating gives an estimated due date of July 12, 2026, so in the true frame her documented delivery on June 17, 1631, falls at about 36 and a half weeks; the gestation at her real delivery is not recorded, so this contradicts no documented fact. The episode ends at 34 weeks 2 days, before delivery, because a modeled birth would fall at or after the true date of her death; a safe delivery is planned but not recorded. The modern episode is a counterfactual and makes no claim about what happened to her.
- **Number of children.** Lahori says she bore eight sons and six daughters (fourteen), and the encyclopedia's table lists fourteen with dates; the state tourism page lists thirteen and calls her last child the thirteenth, apparently omitting the son who died soon after birth in 1622. Fourteen is preferred (Lahori's count, CLM-0010, with the encyclopedia's thirteen births before 1631, CLM-0006, and the fourteenth in June 1631, CLM-0015) and the conflict is recorded (CLM-0012, D, disputed). The fourteenth birth falls after the index date, so it is linked only to the timeline event of her death and appears in no intake document. The modern obstetric history (gravida 14, para 13, seven living children) follows the preferred count; the youngest living child in the modern frame corresponds to Husn Ara, born in April 1630.
- **Labor and cause of death.** Her death in childbirth at Burhanpur is **D** (Lahori; the tourism page). The labor of about 30 hours is **D**, probable, reported by the encyclopedia citing a 2014 case report (Kumar, *Case Reports in Women's Health*) and Kamboh's chronicle; neither was read. Postpartum hemorrhage as the cause is **R**, probable: no contemporary description of bleeding was read, and the term is a modern reading. These claims appear only in the postpartum hemorrhage planning, never as a diagnosis.
- **Interpregnancy interval.** The documented birth of her thirteenth child on 23 April 1630 and of her fourteenth on 17 June 1631 imply, if the last pregnancy reached term, a conception about five months after the previous birth. The modern episode makes the short interpregnancy interval (O09.899) a problem and the reason for anemia, growth surveillance, and contraception counseling.
- **Whereabouts.** Lahori places the emperor and court at Burhanpur in 1040 AH (from August 1630), during the Deccan famine, and she died there in June 1631, so she was with the court on campaign at the index date in the true frame. The modern episode echoes this only as frequent travel with her family.
- **Sources not read.** Encyclopaedia Iranica, Britannica, UNESCO's Taj Mahal page, and Archnet returned HTTP 403 or 429; the Archaeological Survey of India's Taj Mahal page returned only its home page; Kumar (2014) was behind a publisher's bot check; Ebba Koch's *The Complete Taj Mahal* (2006) is available only through lending libraries. None is cited for a claim. The state tourism page's description of her as an “exotic beauty”, its praise of her looks, and the encyclopedia's remarks on her marriage and her husband's other wives are not used.
- **Respect and culture.** The record describes her as a Shi'a Muslim empress of Persian descent, without exoticizing her. The modern episode records her own preferences (women clinicians, a chaperone, languages, daily prayer), her own choice not to fast during Ramadan in pregnancy, and her question about which contraceptive methods her faith permits, answered by explaining that many Muslim scholars permit reversible contraception and that she may consult a religious adviser of her choosing. The clinicians do not decide for her.
- **Relatives.** Her husband, children, father, and aunt appear only in documented claims. The modern episode says only that she is married with seven living children and that six children died young; it names no relative and attributes no statement, decision, or health fact to her husband or any other relative. The family history records the six documented deaths of her children before the index date (two of smallpox, the others with causes not recorded in the cited source).
- **Visit types.** The index visit is the first prenatal visit (the H&P). The four prenatal follow-ups are focused chronic-care visits. The unscheduled sick visit is acute cystitis at 24 weeks, chosen because urinary infection is common in pregnancy and after many births, must always be treated in pregnancy, and teaches drug choice by trimester (nitrofurantoin in the second trimester, not at term) and a test-of-cure culture; it echoes no documented illness. No `preventive_adult` visit is added: prenatal care is the preventive care of pregnancy, and its preventive elements (screening tests, influenza and Tdap vaccines, folic acid, aspirin, mood and intimate partner violence screening) are in the prenatal visits. The RSV vaccine is not offered because the 32- to 36-week window falls outside the season.
- **Drug choices.** Oral iron every other day first, then ferric carboxymaltose 750 mg intravenously twice, four weeks apart, in the second trimester (ACOG Practice Bulletin 233); the RxNorm code is the 15 mL vial (750 mg). Aspirin 81 mg from 13 weeks for two moderate risk factors under the USPSTF (age 35 or older and a previous adverse pregnancy outcome, a baby who died soon after birth). Nitrofurantoin for cystitis at 24 weeks. Oxytocin and tranexamic acid appear only in the birth plan, not as medication records, because the episode ends before delivery.
- **Labs and instruments.** The prenatal panel (blood group and antibody screen, rubella, hepatitis B, HIV, syphilis, hepatitis C), urine cultures, hemoglobin electrophoresis, urine dipsticks, and cell-free DNA results are qualitative and kept in the note text. EPDS (99046-5) is coded in each trimester; all scores are below the threshold with item 10 scored 0, so no safety assessment is required. No `safety_assessment` is recorded.
- **Focused visits.** The four prenatal follow-ups (17, 21, 27, and 34 weeks) are documented as focused visits on ACOG Obstetric Care Consensus No. 11, ACOG Practice Bulletins 183 and 233, the WHO recommendations, and routine prenatal care: blood pressure and urine protein, fetal heart and fundal height, weight, hemoglobin and ferritin, aspirin, anatomy and placental assessment, glucose screening, Tdap, mood screening, travel planning, and the postpartum hemorrhage risk assessment. One deviation is recorded as `deferred`, with its outcome and corrective action, and no result was invented: the visits due at 30 and 32 weeks were missed during six weeks of family travel, so no blood pressure was checked; at 34 weeks blood pressure, urine protein, and growth were normal, and she now has weekly visits, a home blood pressure cuff, and stays near the hospital.
- **Consultation.** The maternal-fetal medicine referral and consultation (Adaeze Montgomery-Rahimi, MD, a fictional consultant, on the day of the 17-week visit) are **S**. The consultant recommends what the record then shows: intravenous iron that day and four weeks later (given at 17 and 21 weeks, with anemia corrected by 27 weeks), an anatomy scan with placental location (normal, no previa or accreta signs, so no repeat scan), aspirin, glucose screening (normal at 27 weeks), two-weekly visits from 28 weeks (missed during travel and recorded as a deviation), a growth scan (done at 34 weeks), birth in a hospital with a blood bank and induction at 39 weeks (chosen at 34 weeks), the hemorrhage plan with oxytocin, quantitative blood loss, and tranexamic acid within 3 hours (agreed at 34 weeks), travel advice, and contraception counseling (done at 34 weeks).
- **Delivery as a judgment call.** The assignment allowed a safe delivery with managed hemorrhage as a counterfactual. It is not modeled, because the episode must end before her true-frame date of death and a delivery near that date would compress the plan; the 34-week visit documents the full prevention and treatment plan instead.
- **Primary clinician.** Farzana Qureshi-Lindholm, MD, is cast as an obstetrician-gynecologist providing her prenatal care.
- Mumtaz Mahal died in 1631, so the recent-death review rule does not apply. Ordinary clinical, provenance, and safe-messaging reviews remain required. Claims about her death in childbirth and the deaths of her children are marked sensitive.
